Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer.


Journal

European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 5 3 2019
medline: 6 8 2019
entrez: 5 3 2019
Statut: ppublish

Résumé

It is of interest to both the clinicians and patients to estimate the probability of death owing to cancer in the presence of other causes as time elapses since diagnosis. The objective of this study was to depict for patients diagnosed with colon cancer between 1990 and 2010 in France, the probability of surviving up to 10 years after diagnosis and to disentangle the probability of death owing to cancer from that of death owing to other causes. Individuals with cancer were described, up to 10 years after diagnosis, as belonging to one of three categories: those who died owing to a cause related to cancer, those who died owing to another cause and those who survived. Net survival, crude probabilities of death related to colon cancer, death related to another cause and survival were estimated by modeling excess mortality hazard. In women of all ages, 5 and 10-year net survival improved over calendar time. The 10-year probability of survival decreased when age increased in both sexes. It was higher in women than in men, and this difference increased with age. Crude probabilities of death related to colon cancer decreased between 1990 and 2010 for men and women, although this was not observed in the eldest men. Crude probability of death related to colon cancer is an important indicator for patients and health policy makers. Results of cancer screening should be faced to trends in probability of death related to colorectal cancer.

Sections du résumé

BACKGROUND
It is of interest to both the clinicians and patients to estimate the probability of death owing to cancer in the presence of other causes as time elapses since diagnosis. The objective of this study was to depict for patients diagnosed with colon cancer between 1990 and 2010 in France, the probability of surviving up to 10 years after diagnosis and to disentangle the probability of death owing to cancer from that of death owing to other causes.
PATIENTS AND METHODS
Individuals with cancer were described, up to 10 years after diagnosis, as belonging to one of three categories: those who died owing to a cause related to cancer, those who died owing to another cause and those who survived. Net survival, crude probabilities of death related to colon cancer, death related to another cause and survival were estimated by modeling excess mortality hazard.
RESULTS
In women of all ages, 5 and 10-year net survival improved over calendar time. The 10-year probability of survival decreased when age increased in both sexes. It was higher in women than in men, and this difference increased with age. Crude probabilities of death related to colon cancer decreased between 1990 and 2010 for men and women, although this was not observed in the eldest men.
CONCLUSION
Crude probability of death related to colon cancer is an important indicator for patients and health policy makers. Results of cancer screening should be faced to trends in probability of death related to colorectal cancer.

Identifiants

pubmed: 30829692
doi: 10.1097/MEG.0000000000001387
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Pagination

570-576

Auteurs

Valérie Jooste (V)

Digestive Cancer Registry of Burgundy, University Hospital of Dijon.
INSERM, U1231.
University of Bourgogne Franche Comté, Dijon.

Anne-Marie Bouvier (AM)

Digestive Cancer Registry of Burgundy, University Hospital of Dijon.
INSERM, U1231.
University of Bourgogne Franche Comté, Dijon.

Nadine Bossard (N)

Biostatistique-Bioinformatique, Hospices Civils de Lyon, F-69003.
Université de Lyon, F-69000, Lyon.
Université Lyon 1, F-69100, Villeurbanne.
CNRS UMR 5558, Laboratoire de Biométrie et Biologie, Évolutive, Équipe Biostatistique Santé, F-69310, Pierre-Bénit.

Zoé Uhry (Z)

Biostatistique-Bioinformatique, Hospices Civils de Lyon, F-69003.
Université de Lyon, F-69000, Lyon.
Université Lyon 1, F-69100, Villeurbanne.
CNRS UMR 5558, Laboratoire de Biométrie et Biologie, Évolutive, Équipe Biostatistique Santé, F-69310, Pierre-Bénit.
Département des Maladies, Non Transmissible et des Traumatismes, Santé Publique France, France.

Gaëlle Coureau (G)

INSERM, U1231.
Biostatistique-Bioinformatique, Hospices Civils de Lyon, F-69003.

Laurent Remontet (L)

Biostatistique-Bioinformatique, Hospices Civils de Lyon, F-69003.
Université de Lyon, F-69000, Lyon.
Université Lyon 1, F-69100, Villeurbanne.
CNRS UMR 5558, Laboratoire de Biométrie et Biologie, Évolutive, Équipe Biostatistique Santé, F-69310, Pierre-Bénit.

Emmanuelle Dantony (E)

Biostatistique-Bioinformatique, Hospices Civils de Lyon, F-69003.
Université de Lyon, F-69000, Lyon.
Université Lyon 1, F-69100, Villeurbanne.
CNRS UMR 5558, Laboratoire de Biométrie et Biologie, Évolutive, Équipe Biostatistique Santé, F-69310, Pierre-Bénit.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH